CRISPR-Based Therapy Analytical Development Summit

CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products. As this paradigm takes place, more complex CRISPR structures necessitate cutting-edge advancements in analytical methods and tools to effectively characterize the genome-edited products utilizing CRISPR technology.

Time: 9:00 am – 3:00 pm

Venue details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Prices:
Drug Developer Pricing – Conference + Workshop Day: USD 4297.00,
Drug Developer Pricing – Conference Only: USD 2999.00,
Academic Pricing – Conference + Workshop Day: USD 3697.00,
Academic Pricing – Conference Only: USD 2599.00,
Solution Provider Pricing – Conference + Workshop Day: USD 5297.00,
Solution Provider Pricing – Conference Only: USD 3799.00

Speakers: Andrew Kernytsky, Principal Consultant, Next Gen Editing, Athea Vichas, Senior Principal Scientist, Bristol Myers Squibb, Bryant Chia, Scientist, Editas Medicine, Carl Co, Senior Director – Research Analytics, Arbor Biotechnologies, CiCi (Xi) Shi, Director, Takeda Pharmaceuticals, and more.